Arda Therapeutics is a TechBio therapeutics company focused on accelerating pathobiology-driven therapeutic development. The company is headquartered in the San Francisco Bay Area.
Subscribe to see Arda Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Arda Therapeutics, Inc. is a biotech company headquartered in United States. Its most recent funding round, Series A, raised $43.3M in September 2024. Xcout tracks 4 named people at Arda Therapeutics, Inc., including Adam Freund (Chief Executive Officer).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $43.3M | 13 named | |
| SEC Form D filing | $7.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Arda Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Xaira Therapeutics is an integrated biotechnology company headquartered in the San Francisco Bay Area in California. The company focuses on leveraging advanced scientific methods for therapeutic discovery and development.
Fauna Bio is a biotechnology company headquartered in Berkeley, California. The company combines animal genomics and advanced data approaches to drive drug discovery and improve human health.
Transcripta Bio is a biotechnology company headquartered in Palo Alto, California, that maps cellular responses to diseases to discover and identify therapeutic molecules.
Standard Model Biomedicine is a biotechnology research company based in San Francisco, United States. The company is focused on developing a foundation model for human biology to advance biomedical research.
GondolaBio is a biotechnology company launched in 2024 as a sister company of BridgeBio Pharma, headquartered in Palo Alto, California. It utilizes a lean, decentralized operational model focused on advancing early-stage drug development.
Gordian Biotechnology is a biotechnology research company headquartered in South San Francisco, California. The company focuses on curing age-related diseases through in vivo target discovery and functional genomics platforms.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Arda Therapeutics, Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.